Attenuation of expression of extracellular matrix genes with siRNAs to SPARC and CTGF in skin fibroblasts of CTGF transgenic mice

International Journal of Immunopathology and Pharmacology

Volumn 24, Issue 3, 2011, Pages 595-601

  Wang, J C ^a,b   Sonnylal, S ^c   Arnett, F C ^b   De Crombrugghe, B ^c   Zhou, Xiaodong ^b  

^a FUDAN UNIVERSITY   (China)

^b UNIVERSITY OF TEXAS   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Ctgf; Fibroblasts; Fibrosis; siRNA; Sparc

Indexed keywords

BETA ACTIN; COLLAGEN TYPE 1; CONNECTIVE TISSUE GROWTH FACTOR; OSTEONECTIN; SMALL INTERFERING RNA; MESSENGER RNA;

ANIMAL CELL; ARTICLE; COL1A2 GENE; CONTROLLED STUDY; CTGF GENE; ENHANCER REGION; EXTRACELLULAR MATRIX; FIBROSIS; GENE; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSLATION; SCLERODERMA; SKIN FIBROBLAST; TRANSGENIC MOUSE; WESTERN BLOTTING; WILD TYPE; ATTENUATION; CELL PROTECTION; GENE EXPRESSION; GROWTH INHIBITION; IN VITRO STUDY; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; STUDENT T TEST; TRANSCRIPTION REGULATION;

EID: 80055111283     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201102400305     Document Type: Article

References (26)

1. Claman HN, Giorno RC, Seibold JR. Endothelial and fibroblastic activation in scleroderma: the myth of the "uninvolved skin." Arthritis Rheum 1991; 34:1495-501.
2. Abraham DJ, Varga J. Scleroderma: from cell and molecular mechanisms to disease models. Trends Immunol 2005; 26:587-95. (Pubitemid 41726446)
3. Sonnylal S, Denton CP, Zheng B, Keene DR, He R, Adams HP. Postnatal induction of transforming growth factor β signaling in fibroblasts of mice recapitulates clinical, histologic, and biochemical features of scleroderma. Arthritis Rheum 2007; 56: 334-44. (Pubitemid 46106207)
4. Border WA, Noble NA. Transforming growth factor β in tissue fibrosis. N Engl J Med 1994; 331:1286-92. (Pubitemid 24333194)
5. Grotendorst GR. Connective tissue growth factor: a mediator of TGF-β action on fibroblasts. Cytokine Growth Factor Rev 1997; 8:171-79. (Pubitemid 28077925)
6. Sonnylal S, Shi-Wen X, Leoni P, et al. Selective expression of connective tissue growth factor in fibroblasts in vivo promotes systemic tissue fibrosis. Arthritis Rheum 2010; 62:1523-532.
7. Brekken RA, Sage EH. SPARC, a matricellular protein: at the crossroads of cell-matrix. Matrix Biol 2001; 19:816-27.
8. Lane TF, Sage EH. The biology of SPARC, a protein that modulates cell-matrix interactions. FASEB J 1994; 8:163-73. (Pubitemid 24067139)
9. Raines EW, Lane TF, Iruela-Arispe ML, Ross R, Sage EH. The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors. Proc Natl Acad Sci USA 1992; 89:1281-85.
10. Zhou X, Tan FK, Reveille JD, Wallis D, Milewicz DM, Ahn C. Association of novel polymorphisms with the expression of SPARC in normal fibroblasts and with susceptibility to scleroderma. Arthritis Rheum 2002; 46:2990-99. (Pubitemid 35315893)
11. Kuhn C, Mason RJ. Immunolocalization of SPARC, tenascin, and thrombospondin in pulmonary fibrosis. Am J Pathol 1995; 147:1759-69.
12. Pichler RH, Hugo C, Shankland SJ, Reed MJ, Bassuk JA, Andoh TF. SPARC is expressed in renal interstitial fibrosis and in renal vascular injury. Kidney Int 1996; 50:1978-89. (Pubitemid 26417541)
13. Frizell E, Liu SL, Abraham A, Ozaki I, Eghbali M, Sage EH. Expression of SPARC in normal and fibrotic livers. Hepatology 1995; 21:847-54.
14. Dhore CR, Cleutjens JP, Lutgens E, Cleutjens KB, Geusens PP, Kitslaar PJ. Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques. Arterioscler Thromb Vasc Biol 2001; 21:1998-2003. (Pubitemid 34219753)
15. Schiemann BJ, Neil JR, Schiemann WP. SPARC inhibits epithelial cell proliferation in part through stimulation of the transforming growth factor-β-signaling system. Mol Biol Cell 2003; 14:3977-88. (Pubitemid 37186302)
16. Zhou X, Tan FK, Guo X, Wallis D, Milewicz DM, Xue S, Arnett FC. Small interfering RNA inhibition of SPARC attenuates the profibrotic effect of transforming growth factor β1 in cultured normal human fibroblasts. Arthritis Rheum 2005; 52:257-61. (Pubitemid 40129255)
17. Zhou X, Tan FK, Guo X, Arnett FC. Attenuation of collagen production with small interfering RNA of SPARC in cultured fibroblasts from the skin of patients with scleroderma. Arthritis Rheum 2006; 54:2626-31. (Pubitemid 44205025)
18. Eckes B, Hunzelmann N, Moinzadeh P, Krieg T. Scleroderma - news to tell. Arch Dermatol Res 2007; 299:139-44. (Pubitemid 46835385)
19. Francki A, Bradshaw AD, Bassuk JA, Howe CC, Couser WG, Sage EH. SPARC regulates the expression of collagen type I and transforming growth factor-β1 in mesangial cells. J Biol Chem 1999; 274:32145-2152.
20. Francki A, McClure TD, Brekken RA, Motamed K, Murri C, Wang T, Sage EH. SPARC regulates TGF-beta1-dependent signaling in primary glomerular mesangial cells. J Cell Biochem 2004; 91:915-25.
21. Chujo S, Shirasaki F, Kawara S, Inagaki Y, Kinbara T, Inaoki M. Connective tissue growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming growth factor-β in a mouse fibrosis model. J Cell Physiol 2005; 203:447-56. (Pubitemid 40471779)
22. Abreu JG, Ketpura NI, Reversade B, De Robertis EM. Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-β. Nat Cell Biol 2002; 4:599-604.
23. Zhou XD, Xiong MM, Tan FK, Guo XJ, Arnett FC. SPARC, an upstream regulator of connective tissue growth factor in response to transforming growth factor β stimulation. Arthritis Rheum 2006; 54:3885-89. (Pubitemid 44955891)
24. Duncan MR, Frazier KS, Abramson S, Williams S, Klapper H, Huang X, Grotendorst GR. Connective tissue growth factor mediates transforming growth factor beta-induced collagen synthesis: down-regulation by cAMP FASEB J 1999; 13:1774-86. (Pubitemid 29473339)
25. Yokoi H, Mukoyama M, Sugawara A, et al. Role of connective tissue growth factor in fibronectin expression and tubulointerstitial fibrosis. Am J Physiol Renal Physiol 2002; 282:933-42.
26. Arnott JA, Nuglozeh E, Rico MC, Arango-Hisijara I, Odgren PR, Safadi FF, Popoff SN. Connective tissue growth factor (CTGF/CCN2) is a downstream mediator for TGF-beta1-induced extracellular matrix production in osteoblasts. J Cell Physiol 2007; 210:843-52. (Pubitemid 46185053)